Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2012-02-14

Name: Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2012-02-14
Creator: Bohai Pharmaceuticals Group, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Bohai Pharmaceuticals Group, Inc. reported in its quarterly report filed 2012-02-14 (fiscal Q2 2012): 39 published measures, 112 facts as tagged in accession 0001144204-12-009041.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-02-14
Fiscal period: fiscal Q2 2012
Accession: 0001144204-12-009041 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Bohai Pharmaceuticals Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-12-31	135,907,087	USD
At 2011-06-30	80,114,919	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-12-31	58,713,439	USD
At 2011-06-30	12,206,912	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2011-12-31	77,193,648	USD
At 2011-06-30	67,908,007	USD
At 2010-06-30	47,775,033	USD
At 2009-06-30	32,064,465	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-12-31	20,433,960	USD
At 2011-06-30	13,344,426	USD
At 2010-12-31	12,422,418	USD
At 2010-06-30	17,149,082	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,295,502	USD	92
2011-07-01 to 2011-12-31	1,360,282	USD	184
2010-07-01 to 2011-06-30	14,004,875	USD	365
2010-10-01 to 2010-12-31	6,540,895	USD	92
2010-07-01 to 2010-12-31	9,553,370	USD	184
2009-07-01 to 2010-06-30	9,056,978	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	11,690,444	USD	184
2010-07-01 to 2010-12-31	6,142,276	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	1,220,889	USD	184
2010-07-01 to 2010-12-31	9,711	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	4,791,004	USD	184
2010-07-01 to 2010-12-31	-3,516,681	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-9,604,548	USD	184
2010-07-01 to 2010-12-31	-7,762,917	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-12-31	45,143,682	USD
At 2011-06-30	43,783,400	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	17,861,085	shares	92
2011-07-01 to 2011-12-31	17,861,085	shares	184
2010-10-01 to 2010-12-31	16,925,928	shares	92
2010-07-01 to 2010-12-31	16,716,691	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	17,861,085	shares	92
2011-07-01 to 2011-12-31	17,861,085	shares	184
2010-10-01 to 2010-12-31	22,266,662	shares	92
2010-07-01 to 2010-12-31	22,258,835	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-0.07	USD/shares	92
2011-07-01 to 2011-12-31	0.08	USD/shares	184
2010-10-01 to 2010-12-31	0.39	USD/shares	92
2010-07-01 to 2010-12-31	0.57	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-0.07	USD/shares	92
2011-07-01 to 2011-12-31	0.08	USD/shares	184
2010-10-01 to 2010-12-31	0.31	USD/shares	92
2010-07-01 to 2010-12-31	0.45	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	2,296,292	USD	92
2011-07-01 to 2011-12-31	4,114,651	USD	184
2010-10-01 to 2010-12-31	1,444,003	USD	92
2010-07-01 to 2010-12-31	2,625,686	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-12-31	11,889,947	USD
At 2011-06-30	5,214,962	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	44,000	USD	184
2010-07-01 to 2010-12-31	103,344	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	8,128,497	USD	92
2011-07-01 to 2011-12-31	14,878,144	USD	184
2010-10-01 to 2010-12-31	6,418,043	USD	92
2010-07-01 to 2010-12-31	11,385,666	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-12-31	50,473,223	USD
At 2011-06-30	31,818,270	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	6,951,562	USD	92
2011-07-01 to 2011-12-31	9,574,073	USD	184
2010-10-01 to 2010-12-31	1,399,366	USD	92
2010-07-01 to 2010-12-31	2,153,370	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-12-31	36,676,612	USD
At 2011-06-30	9,328,515	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-12-31	3,331,537	USD
At 2011-06-30	1,291,907	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2011-12-31	4,973,185	USD
At 2011-06-30	0	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2011-12-31	26,134,958	USD
At 2011-06-30	15,891,642	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-12-31	2,969,822	USD
At 2011-06-30	1,511,021	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	26,854,489	USD	92
2011-07-01 to 2011-12-31	49,838,625	USD	184
2010-10-01 to 2010-12-31	17,523,303	USD	92
2010-07-01 to 2010-12-31	31,105,685	USD	184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	18,725,992	USD	92
2011-07-01 to 2011-12-31	34,960,481	USD	184
2010-10-01 to 2010-12-31	11,105,260	USD	92
2010-07-01 to 2010-12-31	19,720,019	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-12-31	17,861,085	shares
At 2011-06-30	17,861,085	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-12-31	5,214,935	USD
At 2011-06-30	3,559,355	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-12-31	6,600,445	USD
At 2011-06-30	4,312,333	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-12-31	541,079	USD
At 2011-06-30	1,060,138	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	1,000,790	USD	92
2011-07-01 to 2011-12-31	5,474,933	USD	184
2010-10-01 to 2010-12-31	7,984,898	USD	92
2010-07-01 to 2010-12-31	12,179,056	USD	184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-254,522	USD	92
2011-07-01 to 2011-12-31	3,015,862	USD	184
2010-10-01 to 2010-12-31	7,313,330	USD	92
2010-07-01 to 2010-12-31	11,214,174	USD	184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,322	USD	92
2011-07-01 to 2011-12-31	-8,042	USD	184
2010-10-01 to 2010-12-31	1,192	USD	92
2010-07-01 to 2010-12-31	-1,922	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-7,127,707	USD	92
2011-07-01 to 2011-12-31	-9,403,211	USD	184
2010-10-01 to 2010-12-31	1,566,855	USD	92
2010-07-01 to 2010-12-31	793,391	USD	184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	460,185	USD	184
2010-07-01 to 2010-12-31	0	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	3,034,163	USD	184
2010-07-01 to 2010-12-31	3,724,323	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	99,530	USD	184
2010-07-01 to 2010-12-31	1,108,642	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-405,731	USD	184
2010-07-01 to 2010-12-31	888,629	USD	184

Inspect the source

Entity: Bohai Pharmaceuticals Group, Inc. / CIK 0001443242
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 231cd66af3d2b49ce2aa3d470fecf13855af56710429934b8f03d791fb54b2d8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443242.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))